The quantitative trait loci (QTLs) were mapped using a resample inclusion model probability score (RMIP). We used model averaging to map QTLs because of population structure in the stock (1). RMIP is the expected proportion of times a locus is included in a multi-
locus model. An RMIP score of 0.5 indicates that the QTL is included in half of all repeated analyses, estimated by resampling. All QTLs we report have an RMIP > 0.25, which we know from simulation, equates to about one false positive QTL occurring every 4 genome scans. Our primary analysis identified 74 QTLs that influence performance in the behavioral test battery, with 267 genes under their 95% confidence intervals.
We further narrowed this list of genes by constraining the observed QTLs using data available in the progenitor strains. Sequence differences between inbred strains have long been used to map QTL in panels of recombinant inbred lines, by exploiting the fact that a QTL must be contained in a locus where the strain distribution pattern (SDP) correlates with the phenotypic distribution across the panel. Previously we extended this approach to outbred animals derived from known progenitors by incorporating probabilistic ancestral haplotype reconstruction into a merge analysis. The principle behind the merge test is that, to be a functional candidate, the SDP of a genetic variant must match that of the nucleotide variant responsible for the quantitative trait (the quantitative trait nucleotide, QTN). We developed a statistical test of this idea, comparing the fit of the SDP to the genetic action of the QTL (2). The availability of 8.2 million single nucleotide polymorphisms (SNPs) mapped onto common laboratory inbred strains provided the necessary sequence variant resource for the merge analysis.
One drawback to merge analysis is that it indicates regions that can be excluded from consideration, on the basis of the poor fit between SDP and QTL, rather than identifying the most likely position of a QTL. The latter might be indicated by the region where the SDP best fits the QTL; however from a single experiment we do not know how often a maximum merge negative logarithm of the p-value (logP) is likely to coincide with a QTL position. Therefore we generated an empirical distribution of merge logPs by bootstrapping the dataset, and determined by simulation the relationship between the maximum logP and a QTL. This resulted in 52 genes most likely associated with the observed anxiety-related QTLs.
Gene-based Tests
Gene-wise SNP association testing represents a set of nested hypotheses regarding the overall influence of the gene. The non-independence due to linkage disequilibrium complicates gene-wise significance testing. A common method is based on an approach where all tests in a gene are performed and the minimum p-value (minp) among the tests is chosen as the test statistic. Another method aims at assessing the overall significance of the gene and is based on the approach of Fisher (3) 
Population Stratification
Population stratification is a potential source of spurious associations for any populationbased association study. While we did not have a set of ancestry informative markers genotyped in the twin sample to properly investigate this possibility, several prior analyses suggest that this was not likely a major source of error. First, using self-reported ancestry data from this entirely Caucasian sample, we did not detect any evidence of ethnic background differences between cases and controls. Second, using a set of 24 unlinked markers chosen for convenience from other experiments in this sample, the software STRUCTURE (5) found no significant genetic subpopulations. Finally, using the method of Genomic Control (6) on the same 24 unlinked markers, we found no evidence of variance inflation that could be attributed to stratification. In addition to these investigations in the current sample, Sullivan et al. (7) found no evidence for stratification using 16 unlinked microsatellite markers in a prior case-control study of nicotine dependence in another subset of our twin sample (n = 900).
Replication
We attempted to further replicate the association of PPARGC1A gene with our anxietyrelated phenotypes using the MGS "nonGAIN" control sample ([dbgap.ncbi.nlm.nih.gov], Study Accession: phs000167.v1.p1 "nonGAIN sample"). We obtained permission to access this data, which contained genotypes using the Affymetrix 6.0 platform and phenotype information from 1367 control subjects. (Note: we used only this subsample here and not the entire MGS data, since the early release portion of that data from the NIMH control sample was used for gene prioritization, making the twin results dependent on these.) We applied a similar phenotypic procedure as we did to the early release data, again using Mplus to estimate factor scores for the single "internalizing" factor solution for use in genetic association analyses. We analyzed 26
genotyped SNPs available in the PPARGC1A gene in the 1036 nonGAIN subjects available after quality control and excluding subjects from this dataset that overlapped those in the NIMH control sample, but only 5 of these markers were among those we genotyped in the twins.
Several SNPs in and around the gene showed trend level association (p < 0.1). Imputation with MACH 1.0.16 (http://www.sph.umich.edu/csg/abecasis/MaCH/index.html) using HapMap3
(release 2) CEU data provided additional SNPs for analysis, including 16 of the 32 SNPs previously genotyped in the twins. However, strict imputation quality control further reduced our sample to 850 subjects. Using ProbABEL with imputed SNP dosage predicting the factor scores, we found only one additional SNP with trend level association (rs7665116, p = 0.050). All of the replication association data is available in Table S2 . 
